World Wires · story 11280 · unverified · 1 source(s)

Immix Biopharma Announces Closing of $125 Million Underwritten Offering of Common Stock

– Financing includes leading U.S. biotechnology institutional investors and mutual funds – – Financing includes leading U.S. biotechnology institutional in

Open in the desk

Coverage

• Immix Biopharma Announces Closing of $125 Million Underwritten Offering of Common Stock GlobeNewswire: public companies · tier D · clear net · 2026-09-30 21:15 UTC

What this site indexes